RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC) announced today that Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at two upcoming investor conferences:
- Ladenburg Thalmann 2017 Healthcare Conference on Tuesday, September 26, 2017 at 4:00 pm Eastern Time at the Sofitel New York Hotel.
- Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27, 2017 at 9:10 am Eastern Time at the InterContinental New York Barclay Hotel.
About TransEnterix
TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options. The company is focused on the commercialization of the Senhance Surgical Robotic System, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye sensing camera control. The company is also developing the SurgiBot™ System, a single-port, robotically enhanced laparoscopic surgical platform. The Senhance Surgical Robotic System has been granted a CE Mark, and is currently under FDA review for clearance in the United States. For more information, visit the TransEnterix website at www.transenterix.com.
